2024-05-14T07:49:51-05:00 2023-06-30 520982413 GROSS MENDELSOHN & ASSOCIATES PA 1801 PORTER STREET SUITE 500 BALTIMORE MD 21230 990 2022-07-01 520856660 EPILEPSY FOUNDATION OF AMERICA EPIL 8003321000 3540 CRAIN HIGHWAY 675 BOWIE MD 20716 RAHEL ROSNER CFOO 3019183702 2024-05-14 1 RAHEL ROSNER XXX-XX-XXXX 0 LISA JOHNSON P01250416 4106855512 2024-05-13 0 AAL1 IAL1 2022 2023-04-26 12:10:37Z RAHEL ROSNER 3540 CRAIN HIGHWAY 675 BOWIE MD 20716 23675715 0 X WWW.EPILEPSY.COM X 1967 DE TO IMPROVE THE LIVES OF PEOPLES AFFECTED BY EPILEPSY THROUGH EDUCATION, ADVOCACY, RESEARCH, AND CONNECTION. 23 23 93 900 0 0 20369605 18834892 642816 703581 2003827 -954167 -1119081 -743092 21897167 17841214 700539 356078 0 0 8323322 8224389 276575 234025 2228645 8432662 7166841 17733098 15981333 4164069 1859881 20384765 21649278 3187329 1740500 17197436 19908778 TO IMPROVE THE LIVES OF PEOPLES AFFECTED BY EPILEPSY THROUGH EDUCATION, ADVOCACY, RESEARCH, AND CONNECTION. 0 0 9127281 407605 ADVOCACY AND SERVICES FOR INDIVIDUALS, FAMILIES, AND COMMUNITIES - DESIGNED TO ENSURE THAT ALL PEOPLE LIVING WITH EPILEPSY AND SEIZURE DISORDERS, AND THIER FAMILIES AND COMMUNITIES, RECEIVE THE BEST POSSIBLE SERVICES AND CARE. THE FOUNDATION DEVELOPS NATIONWIDE PROGRAMS AVAILABLE THROUGH ITS NETWORK OF NEARLY FIFTY LOCAL EPILEPSY FOUNDATIONS AND CAN ALSO BE FOUND ON EPILEPSY.COM. PROGRAMS AND INITIATIVES FOCUS ON ENGAGING PARENTS, CHILDREN AND ADULTS ON IMPROVING THEIR QUALITY OF LIFE. THE FOUNDATION ALSO HAS PROGRAMS DEDICATED TO ENDING EARLY DEATH FROM EPILEPSY AND IMPROVING OVERALL WELLNESS. THE PROGRAMS ARE DESIGNED TO BE CULTURALLY AND ETHNICALLY DIVERSE. THE FOUNDATION AND ITS GRASSROOTS VOLUNTEERS ACROSS THE COUNTRY ADVOCATE AT THE FEDERAL AND STATE LEVELS TO SECURE FUNDING FOR EPILEPSY PROGRAMS. 1957106 295976 PUBLIC HEALTH, EDUCATION, AND AWARENESS - PROVIDES EDUCATIONAL AND SUPPORTING SERVICES THAT CREATE AND PROMOTE PUBLIC AWARENESS SURROUNDING EPILEPSY. THE PROGRAM UTILIZES TRADITIONAL AND DIGITAL MEDIA CHANNELS INCLUDING SOCIAL MEDIA AND THROUGH THE DIRECT MAIL PROGRAM WHICH SERVE THE DUAL PURPOSE OF RAISING FUNDS FOR THE FOUNDATION AND INCREASING AWARENESS OF THE FOUNDATION'S CAUSE. THE FOUNDATION EDUCATES THROUGH ENGAGEMENT WITH MEDIA SOURCES, AND PARTNERSHIPS WITH OTHER NON-PROFITS AND PROFESSIONAL AND GOVERNMENT ORGANIZATIONS. IN ADDITION, THE FOUNDATION ESTABLISHED THE EPILEPSY LEARNING HEALTHCARE SYSTEM (ELHS) NETWORK, WHICH IS A PUBLIC HEALTH INITIATIVE TO DRIVE QUALITY HEALTH SERVICES RESEARCH TO IMPROVE MEDICAL OUTCOMES FOR PEOPLE WITH EPILEPSY. 1170899 356078 RESEARCH, INNOVATION, AND NEW THERAPIES - ACCELERATES THE DEVELOPMENT OF INNOVATIVE THERAPIES, PREVENTION, AND CURES FOR ALL FORMS OF EPILEPSIES, AND SEEKS TO ADDRESS THE GAP IN THE RESEARCH AND COMMERCIALIZATION CONTINUUM. THE MAIN OBJECTIVE IS TO DEVELOP AN EPILEPSY RESEARCH ECOSYSTEM THAT COVERS ALL PARTS OF THERAPY, FROM IDEA TO MARKET. THE FOUNDATION'S RESEARCH INITIATIVES INCLUDE: INNOVATION PROGRAMS THAT TEST NEW IDEAS AND FOLLOW NEW RESEARCH LEADS AND ENGAGEMENT PROGRAMS THAT IMPROVE COMMUNICATION BETWEEN PEOPLE WITH EPILEPSY, THEIR FAMILIES, ADVOCATES, RESEARCHERS, AND INVESTORS. DIGITAL TOOLS THAT SUPPORT RESEARCH INFRASTRUCTURE. FUNDING THAT SUPPORTS YOUNG RESEARCHERS TO BRING THEIR IDEAS TO LIFE. PRACTICE SOLUTIONS TO ERADICATE SUDDEN AND UNEXPECTED DEATH IN EPILEPSY (SUDEP). 12255286 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 0 1 0 0 1 0 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 1 56 0 1 93 1 0 0 0 0 0 0 0 0 0 0 X 23 23 0 1 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AR AL CA FL GA HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X X RAHEL ROSNER 3019183702 3540 CRAIN HIGHWAY 675 BOWIE MD 20716 JEFFREY PARENT CHAIR 1.00 0.10 X X 0 0 0 COURTNEY WATSON VICE CHAIR 1.00 0.10 X X 0 0 0 MARK THEEUWES SECRETARY 1.00 0.10 X X 0 0 0 DANIEL MOORE TREASURER 1.00 0.10 X X 0 0 0 CURTIS DEPREY DIRECTOR 1.00 0.10 X 0 0 0 CAMILA COELHO DIRECTOR 1.00 0.10 X 0 0 0 ELIZABETH CORBETT DIRECTOR 1.00 0.10 X 0 0 0 ABRAHAM GLASER DIRECTOR 1.00 0.10 X 0 0 0 JOSHUA GOLDEN DIRECTOR 1.00 0.10 X 0 0 0 WASIM MALIK DIRECTOR 1.00 0.10 X 0 0 0 DAVID HAWK DIRECTOR 1.00 0.10 X 0 0 0 GREG MAYES DIRECTOR 1.00 0.10 X 0 0 0 ALI HERON DIRECTOR 1.00 0.10 X 0 0 0 JAMES MCALPIN DIRECTOR 1.00 0.10 X 0 0 0 SARAH KLEIN DIRECTOR 1.00 0.10 X 0 0 0 MICHAEL MCDONNELL DIRECTOR 1.00 0.10 X 0 0 0 DAVID MOORE DIRECTOR 1.00 0.10 X 0 0 0 MATT TIFFT DIRECTOR 1.00 0.10 X 0 0 0 NOAH RICHMOND DIRECTOR 1.00 0.10 X 0 0 0 REBEKAH WALKER DIRECTOR 1.00 0.10 X 0 0 0 ANGELICA ROIZ DIRECTOR 1.00 0.10 X 0 0 0 MARY WELDON DIRECTOR 1.00 0.10 X 0 0 0 RON SHIMABUKU DIRECTOR 1.00 0.10 X 0 0 0 ALISON ZETTERQUIST INTERIM CHIEF EXECUTIVE OFFICER 35.00 0.10 X 165778 0 0 LAURA THRALL CHIEF EXECUTIVE OFFICER UNTIL OCT 2022 35.00 0.10 X 457649 0 30563 RAHEL ROSNER CHIEF FINANCE AND OPERATING OFFICER 35.00 0.10 X 269600 0 37589 BRANDY FUREMAN CHIEF OUTCOME OFFICER 35.00 0.10 X 232853 0 47694 GEOFFREY DELIZZIO CHIEF DEVELOPMENT OFFICER 35.00 0.10 X 234996 0 39707 LAURA WEIDNER CHIEF ADVOCACY OFFICER 35.00 0.10 X 185139 0 20480 NATHAN DEVAULT VP, MARKETING AND COMMUNICATIONS 35.00 0.10 X 160560 0 29301 KATHLEEN FARRELL VP, PUBLIC HEALTH & OUTCOMES 35.00 0.10 X 140000 0 35352 DANIELLE SOLOMON VP, HUMAN RESOURCES 35.00 0.10 X 145506 0 21022 GREGG FORTT VP, REGIONAL TEAMS 35.00 0.10 X 133000 0 19632 2125081 0 281340 10 0 1 0 HEADLINE STUIDO 1 WORLD TRADE CENTER NEW YORK NY 10007 COMMUNICATIONS AGENCY 157450 JACQUELINE A FRENCH MD 11 NARWYN LANE NARBETH PA 19072 CONTRACT AS CHIEF MEDICAL AND INNOVATION 126750 JEFFREY BUCHHALTER 13030 N 17TH PLACE PHOENIX AZ 85022 CO-INVESTIGATOR EPILEPSY LEARNING HEALTH 118750 3 2608242 4310582 11916068 1057926 18834892 AFFILIATE FEES 900099 407605 407605 ELHS MEMBERSHIP 900099 295976 295976 703581 428539 428539 1806 1806 3586028 4968734 -1382706 -1382706 -1382706 67319 2608242 865767 -798448 -798448 MISCELLANEOUS REVENUE 900099 53550 0 53550 53550 17841214 703581 0 -1697259 X 356078 356078 1367114 832104 251041 283969 5635131 4373505 545652 715974 337771 260427 33599 43745 622944 476254 64063 82627 261429 195089 29362 36978 82232 65756 4328 12148 94168 75300 4957 13911 234025 234025 57145 45695 3008 8442 4697817 3943677 259597 494543 842550 449561 166387 226602 126087 120511 2184 3392 518675 484269 22405 12001 464200 464200 105345 27945 67896 9504 140293 84915 27689 27689 OTHER GRANTS 23095 23095 BAD DEBT 15234 15234 15981333 12255286 1497402 2228645 3843898 4242331 381656 313172 1340659 408246 35164 386238 225000 83222 3777 375431 583843 579051 505601 141487 73450 10308126 12077261 443715 250000 3285852 3231515 20384765 21649278 2812619 1175850 204710 170000 120024 0 444626 3187329 1740500 X 10747660 14405813 6449776 5502965 17197436 19908778 20384765 21649278 X 1859881 593627 349679 -91845 X 0 1 X 1 1 1 X 19683958 28581224 18909147 20369605 18834892 106378826 19683958 28581224 18909147 20369605 18834892 106378826 106378826 271307 266329 299873 88 430345 1267942 82850 28735 11325 125457 53550 301917 107948685 0.98550 0.90240 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 13165 240383 253548 15727785 15981333 949067 237267 0 0 1000000 1000000 1000000 949067 3949067 5923601 262489 186571 411729 253548 1114337 250000 250000 250000 237267 987267 1480901 11732 46276 49458 13165 120631 4349419 -50705 -41140 4257574 4896037 -546368 -250 4349919 6334076 781076 2219115 4896037 6627103 -257981 35046 6328108 6349545 278465 907 6627103 1.00000 0 0 579051 505601 73450 73450 DEPOSITS 8297 AFFILIATE DUES 30503 BENEFICIAL INTEREST IN PERPETUAL TRUST 3131223 OPERATING LEASE RIGHT OF USE ASSETS 61492 3231515 OPERATING LEASE RIGHT OF USE LIABILITIES 61589 DUE TO AFFILIATE 383037 444626 X PART V, LINE 4: THE ENDOWMENT FUNDS INCLUDE PERPETUAL FUNDS HELD BY OUTSIDE INVESTMENT COMPANIES. INCOME IS EITHER FOR THE UNRESTRICTED USE OF THE FOUNDATION OR FOR RESEARCH PURPOSES. PART X, LINE 2: THE FOUNDATION AND ITS CONSOLIDATED NONPROFIT AFFILIATES ARE CHARITABLE ORGANIZATIONS UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND, AS SUCH, ARE EXEMPT FROM FEDERAL AND STATE INCOME TAXES. EPILEPSY VENTURES FUND IS CONSIDERED A DISREGARDED ENTITY, AND IS THEREFORE NOT REQUIRED TO FILE A SEPARATE INCOME TAX RETURN AS THE REVENUE AND EXPENSES ARE REFLECTED ON THE FOUNDATION'S TAX RETURN. INCOME THAT IS NOT RELATED TO EXEMPT PURPOSES, LESS APPLICABLE DEDUCTIONS, IS SUBJECT TO FEDERAL AND STATE INCOME TAXES. THE FOUNDATION HAD NO UNRELATED BUSINESS INCOME FOR THE YEAR. ACCORDINGLY, NO PROVISION FOR INCOME TAXES IS REFLECTED IN THESE STATEMENTS. THE FOUNDATION'S FEDERAL EXEMPT ORGANIZATION TAX RETURNS ARE SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE, GENERALLY FOR A PERIOD OF THREE YEARS AFTER THE RETURNS ARE FILED. SCHEDULE D, PART XIII THE CHANGE IN SPLIT INTEREST WAS ELIMINATED FOR TAX REPORTING. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES ANNUAL SUBSCRIPTIONS 22755 NORTH AMERICA 0 0 PROGRAM SERVICES CONSULTING 269478 0 0 0 0 0 0 292233 0 292233 0 0 0 0 0 0 PART I, LINE 2: THE ORGANIZATION GENERALLY REQUIRES DOCUMENTATION OF EXPENDITURES AND ACHIEVEMENT OF GOALS OF GRANT. PART III ACCOUNTING METHOD: X X X X X X X 1 HH GLOBAL 203 N LASALLE CHICAGO IL 60601 FUNDRAISING CONSULTANT 0 923029 234025 689004 923029 234025 689004 AL AK AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MS MO NV NH NJ NM NY NC OH OK OR PA RI SC TN UT VA WA WV WI WALK TO END EPILEPSY 1410716 1410716 62570 10858 19181 195167 GALA 239810 209810 30000 22181 17 1025035 987716 37319 20374 50594 53500 431342 2675561 2608242 67319 105125 61452 72681 626509 865767 -798448 1 GORDON RESEARCH CONFERENCE 512 LIBERTY LANE WEST KINGSTON RI 02892 260150662 501(C)(3) 10000 0 SUPPORT THE GORDON RESEARCH CONFERENCE AMERICAN EPILEPSY SOCIETY 135 S LASSALE ST STE 2850 CHICAGO IL 60603 046112600 501(C)(3) 50000 0 SUPPORT A YOUNG RESEARCHER IN THE FIELD OF EPILEPSY AMERICAN BRAIN FOUNDATION 201 CHICAGO AVENUE SOUTH MINNEAPOLIS MN 55415 411717098 501(C)(3) 50000 0 SUPPORT THE CLINICAL RESEARCH TRAINING SCHOLARSHIP MAYO CLINIC 200 FIRST STREET NW ROCHESTER MN 55905 416011702 501(C)(3) 237494 0 SEIZURE GAUGE GRANT PART I, LINE 2: THE ORGANIZATION GENERALLY REQUIRES DOCUMENTATION OF EXPENDITURES AND ACHIEVEMENT OF GOALS OF GRANTS. X X X X X X 1 0 0 0 0 0 0 0 0 LAURA THRALL CHIEF EXECUTIVE OFFICER UNTIL OCT 20 301875 0 114713 0 41061 0 0 0 30563 0 488212 0 0 0 RAHEL ROSNER CHIEF FINANCE AND OPERATING OFFICER 249600 0 20000 0 0 0 0 0 37589 0 307189 0 0 0 BRANDY FUREMAN CHIEF OUTCOME OFFICER 222853 0 10000 0 0 0 0 0 47694 0 280547 0 0 0 GEOFFREY DELIZZIO CHIEF DEVELOPMENT OFFICER 224996 0 10000 0 0 0 0 0 39707 0 274703 0 0 0 LAURA WEIDNER CHIEF ADVOCACY OFFICER 182139 0 3000 0 0 0 0 0 20480 0 205619 0 0 0 NATHAN DEVAULT VP, MARKETING AND COMMUNICATIONS 157560 0 3000 0 0 0 0 0 29301 0 189861 0 0 0 KATHLEEN FARRELL VP, PUBLIC HEALTH & OUTCOMES 137000 0 3000 0 0 0 0 0 35352 0 175352 0 0 0 DANIELLE SOLOMON VP, HUMAN RESOURCES 142506 0 3000 0 0 0 0 0 21022 0 166528 0 0 0 ALISON ZETTERQUIST INTERIM CHIEF EXECUTIVE OFFICER 165778 0 0 0 0 0 0 0 0 0 165778 0 0 0 GREGG FORTT VP, REGIONAL TEAMS 130000 0 3000 0 0 0 0 0 19632 0 152632 0 0 0 PART I, LINE 4A LAURA THRALL RECEIVED A SEVERANCE PAYMENT OF 150,938. X 849727 FMV X 21 208199 FMV 0 1 1 PART I, LINE 32B: A SEPARATE COMPANY COLLECTS DONATED ITEMS ON BEHALF OF THE ORGANIZATION AND SELLS SUCH ITEMS ON BEHALF OF THE ORGANIZATION. THE COMPANY THEN REMITS THE FUNDS RECEIVED FROM THE SALE OF THESE ITEMS TO THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 3 FROM OCTOBER 2022 THROUGH JUNE 2023, THE ORGANIZATION ENGAGED A CONSULTANT TO PERFORM THE DUTIES OF INTERIM CEO DURING CEO TRANSITION. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTANTS AND AN ELECTRONIC COPY OF THE DRAFT FORM 990 WAS SENT TO ALL BOARD MEMBERS BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C THE EPILEPSY FOUNDATION HAS A CONFLICT OF INTEREST POLICY AS PART OF ITS CODE OF ETHICS THAT IS SHARED WITH ALL VOLUNTEERS, BOARD MEMBERS, EMPLOYEES, AND AFFILIATES. BOARD MEMBERS AND STAFF ANNUALLY COMPLETE A WRITTEN CONFLICT OF INTEREST DISCLOSURE STATEMENT, WHICH IS KEPT ON FILE AT FOUNDATION HEADQUARTERS. FOUNDATION POLICY REQUIRES ANYONE WITH A CONFLICT OF INTEREST TO REVEAL THE CONFLICT DURING ANY DISCUSSIONS, DECISIONS, OR ACTIONS THAT TAKE PLACE IN WHICH A CONFLICT MAY ARISE, AND TO RECUSE HIM OR HERSELF FROM THE DECISION MAKING OR ACTION ITEM. THE EXECUTIVE COMMITTEE MAINTAINS AND REVIEWS THE CONFLICT OF INTEREST DISCLOSURE STATEMENTS FROM BOARD MEMBERS. FORM 990, PART VI, SECTION B, LINE 15 EPILEPSY FOUNDATION HAS A COMPENSATION COMMITTEE THAT SETS COMPENSATION FOR THE PRESIDENT AND CEO. THE COMMITTEE ALSO REVIEWS AND APPROVES ALL COMPENSATION FOR C-SUITE EXECUTIVES (KEY EMPLOYEES). THE CEO IS HIRED AND COMPENSATION TERMS ARE SET BY A CONTRACT WHICH HAS BEEN DEVELOPED BY THE COMPENSATION COMMITTEE OF THE BOARD AND APPROVED BY THE BOARD OF DIRECTORS. THE COMPENSATION COMMITTEE IS MADE UP OF EPILEPSY FOUNDATION OFFICERS AND BOARD MEMBERS, ALL WHO ARE VOLUNTEERS, AND INCLUDES THE CEO AS A NONVOTING MEMBER. DURING THE PROCESS FOR CONTRACT DETERMINATION, THE CEO IS RECUSED FROM ALL MEETINGS OF THE COMPENSATION COMMITTEE THAT CONCERN HIS/HER CONTRACT TERMS. THE CHAIR OF THE FOUNDATION NEGOTIATES THE TERMS OF THE CONTRACT WITH THE CEO UNDER THE DIRECTION AND WITH APPROVAL OF TERMS ESTABLISHED BY THE COMPENSATION COMMITTEE OF THE BOARD. IN ORDER TO DETERMINE AN APPROPRIATE SALARY AND COMPENSATION, THE COMPENSATION COMMITTEE REVIEWS COMPARABLE DATA FROM THE WASHINGTON, DC METRO AREA FOR THE CEO POSITION, AS WELL AS DATA FROM THE NATIONAL HEALTH COUNCIL ON COMPENSATION OF CEOS FOR COMPARABLY SIZED AND SIMILARLY SITUATED NONPROFIT ENTITIES. SOURCES REVIEWED AT LAST CONTRACT NEGOTIATION FOR THE CEO INCLUDED THE NATIONAL HEALTH COUNCIL SURVEY DATA, THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES SURVEY FOR THE WASHINGTON, DC METRO AREA, DATA FROM THE AMERICAN RESEARCH COMPANY'S GENERAL SURVEY, AND HEALTH AND DISEASE SEGMENT FOR ALL GEOGRAPHY, FOR THE DC METRO AREA. BASED UPON THIS DATA, A SALARY RANGE IS DETERMINED FOR THE CEO POSITION. MINUTES OF THE COMPENSATION COMMITTEE DELIBERATIONS AND ACTIONS CONCERNING COMPENSATION ARE KEPT AT THE FOUNDATION'S HEADQUARTERS EPILEPSY FOUNDATION OF AMERICA 52-0856660 OFFICE. IN ADDITION, THE SIGNED CONTRACT SETTING SALARY AND COMPENSATION AND ALL TERMS OF EMPLOYMENT FOR THE CEO ARE MAINTAINED IN THE FOUNDATION'S HEADQUARTERS. DOCUMENTATION OF THE DATA SOURCES, THE COMPARATIVE EVALUATIONS MADE, AND THE RESULTS OF THE COMPENSATION COMMITTEE DELIBERATIONS, AND MINUTES OF MEETINGS DURING EXECUTIVE SESSION ARE ALSO INCLUDED IN THESE FILES. ANNUAL REVIEW OF CEO PERFORMANCE IS DONE BY THE COMPENSATION COMMITTEE IN EXECUTIVE SESSION (WITHOUT THE CEO BEING PRESENT), WITH A FORMAL WRITTEN REVIEW REQUIRED. THIS PERFORMANCE REVIEW SERVES AS THE BASIS FOR AN ANNUAL BONUS FOR THE CEO, IF ANY, WITHIN THE TERMS OF THE CEO CONTRACT. FORM 990, PART VI, SECTION C, LINE 19 THE EPILEPSY FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS: PROGRAM SERVICE EXPENSES 3,943,677. MANAGEMENT AND GENERAL EXPENSES 259,597. FUNDRAISING EXPENSES 494,543. TOTAL EXPENSES 4,697,817. FORM 990, PART XI, LINE 9: CHANGE IN SPLIT INTEREST -91,845. EPILEPSY VENTURES FUND LLC 3540 CRAIN HIGHWAY STE 675 BOWIE MD 20716 EPILEPSY INVESTMENTS DE EPILEPSY FOUNDATION OF AMERICA EPILEPSY REASEARCH FOUNDATION 3540 CRAIN HIGHWAY STE 675 BOWIE MD 20716 562369930 RESEARCH MD 501(C)(3) LINE 12A, I EPILEPSY FOUNDATION OF AMERICA 0 EPILEPSY SERVICES OF WEST CENTRAL FLORIDA 1046 EAST BRANDON BOULEVARD STE 3 BRANDON FL 33511 593151484 RESEARCH FL 501(C)(3) LINE 7 EPILEPSY FOUNDATION OF AMERICA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0